title: Lung cancer screening: the European perspective.
abstract: European studies have contributed significantly to the understanding of lung cancer screening. Smoking within screening, quality of life, nodule management, minimally invasive treatments, cancer prevention programs, and risk models have been extensively investigated by European groups. Mortality data from European screening studies have not been encouraging so far, but long-term results of the NELSON study are eagerly awaited. Investigations on molecular markers of lung cancer are ongoing in Europe; preliminary results suggest they may become an important screening tool in the future.
authors.affiliation: Lung Cancer Early Detection Unit, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: giulia.veronesi@ieo.it.
authors.forename: Giulia
authors.initials: G
authors.lastname: Veronesi
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood; D055088:Early Detection of Cancer / Q000379:methods; D005060:Europe; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000209:etiology / Q000517:prevention & control / Q000601:surgery; D008875:Middle Aged; D011788:Quality of Life; D011829:Radiation Dosage; D016032:Randomized Controlled Trials as Topic; D012907:Smoking / Q000009:adverse effects; D003074:Solitary Pulmonary Nodule / Q000000981:diagnostic imaging; D014057:Tomography, X-Ray Computed
chemical_list: D014408:Biomarkers, Tumor
keywords: Computed tomography; Diagnostic algorithm; Early-stage lung cancer; Lung cancer; Survival